A network medicine approach for identifying diagnostic and prognostic biomarkers and exploring drug repurposing in human cancer

Cancer is a heterogeneous disease mainly driven by abnormal gene perturbations in regulatory networks. Therefore, it is appealing to identify the common and specific perturbed genes from multiple cancer networks. We developed an integrative network medicine approach to identify novel biomarkers and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Le, Fan, Shiwei, Vera, Julio, Lai, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732137/
https://www.ncbi.nlm.nih.gov/pubmed/36514340
http://dx.doi.org/10.1016/j.csbj.2022.11.037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732137/
https://www.ncbi.nlm.nih.gov/pubmed/36514340
http://dx.doi.org/10.1016/j.csbj.2022.11.037

Ejemplares similares